Pyrophyte II Reports $102K Loss, Raises $200M+ in IPO for SPAC Hunt

TL;DR

**PAII-WT is a pre-deal SPAC with $200M in the bank, but the clock is ticking to find a target or face liquidation.**

AI Summary

Pyrophyte Acquisition Corp. II (PAII-WT), a blank check company, reported a net loss of $102,000 for the period from inception (May 1, 2025) through June 30, 2025, primarily due to general and administrative expenses. The company had total assets of $217,104, consisting entirely of deferred offering costs, and total liabilities of $294,104, including a $75,000 promissory note to a related party. Shareholder's deficit stood at $77,000. Post-quarter, on July 18, 2025, the company consummated its initial public offering, raising $175,000,000 from 17,500,000 units at $10.00 each. An additional $25,411,500 was raised on July 24, 2025, from the partial exercise of the over-allotment option for 2,541,150 units. Simultaneously, a private placement of 5,050,000 warrants generated $5,050,000. A total of $200,411,500 from these proceeds was deposited into a trust account, with $1,500,000 held outside for working capital. The company's strategic outlook is focused on completing a business combination within 24 months from the IPO closing, with a target fair market value of at least 80% of net assets in the trust account.

Why It Matters

For investors, Pyrophyte Acquisition Corp. II's 10-Q highlights its status as a pre-deal SPAC, with its financial health largely dependent on its ability to identify and merge with a suitable target within 24 months. The $200.4 million in the trust account provides significant capital for a potential acquisition, but the $102,000 net loss and $77,000 shareholder deficit underscore the burn rate of operating expenses before a business combination. The competitive SPAC market means Pyrophyte II must find an attractive target to deliver value, or risk liquidation, which would return approximately $10.00 per share to public shareholders, but without the upside of a successful merger.

Risk Assessment

Risk Level: high — The risk level is high because Pyrophyte Acquisition Corp. II is a blank check company with no operations and a limited lifespan of 24 months from its IPO to complete a business combination. As of June 30, 2025, it had an accumulated deficit of $102,000 and total liabilities exceeding total assets, indicating a pre-revenue, pre-deal status with inherent uncertainty.

Analyst Insight

Investors should monitor Pyrophyte Acquisition Corp. II for announcements regarding a potential business combination target. Given its blank check status, this is a speculative investment; consider the 24-month deadline for a merger and the potential for liquidation if no suitable target is found, which would return approximately $10.00 per share.

Financial Highlights

debt To Equity

N/A

revenue

$0

operating Margin

N/A

total Assets

$ 217,104

total Debt

$ 294,104

net Income

$ (102,000)

eps

$ (0.02)

gross Margin

N/A

cash Position

$ 217,104

revenue Growth

N/A

Key Numbers

• $102,000 — Net Loss (for the period from May 1, 2025 (inception) through June 30, 2025)
• $217,104 — Total Assets (as of June 30, 2025, primarily deferred offering costs)
• $294,104 — Total Current Liabilities (as of June 30, 2025, including a $75,000 related-party promissory note)
• $77,000 — Total Shareholders' Deficit (as of June 30, 2025)
• $175,000,000 — Gross Proceeds from IPO (from 17,500,000 units at $10.00 each on July 18, 2025)
• $25,411,500 — Gross Proceeds from Over-allotment (from 2,541,150 units at $10.00 each on July 24, 2025)
• $5,050,000 — Gross Proceeds from Private Placement (from 5,050,000 warrants at $1.00 each)
• $200,411,500 — Funds in Trust Account (total deposited after IPO and over-allotment exercise)
• 24 months — Deadline for Business Combination (from the closing of the initial public offering)
• 80% — Minimum Fair Market Value (of target business relative to net assets in trust account)

Key Players & Entities

• Pyrophyte Acquisition Corp. II (company) — registrant
• UBS Securities LLC (company) — underwriter representative
• Brookline Capital Markets (company) — underwriter
• Pyrophyte Acquisition II LLC (company) — sponsor
• Continental Stock Transfer & Trust Company (company) — trustee for the Trust Account
• SEC (regulator) — U.S. Securities and Exchange Commission

FAQ

Risk Factors

• Dependence on Business Combination Target [high — operational]: The company is a blank check company with no operating history. Its success is entirely dependent on identifying and completing a business combination within 24 months of the IPO closing. Failure to do so will result in dissolution and return of funds to shareholders, potentially impacting investor returns.
• Limited Working Capital Outside Trust [medium — financial]: Following the IPO and related transactions, only $1,500,000 was allocated for working capital outside the trust account. This limited capital may restrict the company's ability to fund operations, pursue potential targets, and cover expenses during the search period.
• Related Party Indebtedness [low — financial]: As of June 30, 2025, the company had a $75,000 promissory note to a related party. While this note was outstanding prior to the IPO, its terms and repayment schedule could impact the company's financial flexibility.
• Regulatory Scrutiny of SPACs [medium — regulatory]: The SPAC market faces increasing regulatory scrutiny. Changes in regulations concerning SPACs, their structure, or disclosure requirements could impact the company's ability to complete a business combination or its overall valuation.
• Market Volatility and IPO Market Conditions [medium — market]: The success of the business combination is subject to prevailing market conditions and investor sentiment towards SPACs and the target industry. Adverse market conditions could hinder the ability to secure favorable terms or complete the transaction.

Industry Context

Pyrophyte Acquisition Corp. II operates within the Special Purpose Acquisition Company (SPAC) sector, a segment of the financial services industry focused on facilitating public listings for private companies. The SPAC market has experienced significant growth and subsequent volatility, with increasing regulatory attention. Companies like PAII-WT aim to leverage this structure to bring target businesses to public markets, often within specific industry focuses, though PAII-WT's target industry is not yet defined.

Regulatory Implications

As a SPAC, Pyrophyte Acquisition Corp. II is subject to SEC regulations governing financial reporting, disclosures, and the process of business combinations. The evolving regulatory landscape for SPACs, including potential changes to accounting rules, disclosure requirements, and liability frameworks, presents ongoing compliance challenges and could impact the feasibility and terms of its future merger.

What Investors Should Do

1. Monitor Target Announcement and Deal Terms
2. Evaluate Management's Execution Capability
3. Understand Trust Account Dynamics

Key Dates

• 2025-05-01: Company Inception — Marks the beginning of Pyrophyte Acquisition Corp. II's operational period.
• 2025-06-30: Quarter End Balance Sheet Date — Provides a snapshot of the company's financial position before the IPO, showing minimal assets and a shareholder deficit.
• 2025-07-18: Initial Public Offering (IPO) Consummation — Raised $175,000,000, providing capital for the business combination and marking the start of the 24-month search period.
• 2025-07-24: Partial Exercise of Over-allotment Option — Raised an additional $25,411,500, increasing the total capital available for the business combination.
• 2025-07-24: Sponsor Forfeiture of Class B Shares — Resulted from the partial exercise of the over-allotment option, reducing the sponsor's equity stake.

Glossary

Blank Check Company

A shell corporation that is established to raise capital through an initial public offering (IPO) for the purpose of acquiring or merging with an existing company. (Pyrophyte Acquisition Corp. II is structured as a blank check company, meaning its primary purpose is to find and merge with another business.)

Deferred Offering Costs

Expenses incurred in connection with the preparation and execution of an initial public offering that have not yet been expensed. These are typically capitalized and offset against the proceeds of the offering. (These costs represent the majority of the company's assets as of June 30, 2025, reflecting the expenses related to its upcoming IPO.)

Shareholders' Deficit

A situation where a company's total liabilities exceed its total assets, resulting in a negative net worth for shareholders. (The company had a shareholders' deficit of $77,000 as of June 30, 2025, indicating that liabilities surpassed assets before the IPO proceeds were received.)

Promissory Note – Related Party

A written promise to pay a specific sum of money to a related party (e.g., an executive, director, or major shareholder) under specified terms. (The company had a $75,000 promissory note to a related party as of June 30, 2025, highlighting potential conflicts of interest or financial arrangements with insiders.)

Over-allotment Option (Greenshoe)

An option granted by an issuing company to underwriters to sell additional shares or units beyond the initial offering size, typically to stabilize prices after the IPO. (The partial exercise of this option on July 24, 2025, provided additional capital to the company.)

Class B Ordinary Shares

A class of shares often issued to founders or sponsors of a SPAC, typically carrying different voting rights or subject to forfeiture conditions. (These shares were issued to the sponsor and were subject to forfeiture based on the exercise of the over-allotment option.)

Year-Over-Year Comparison

This is the first 10-Q filing for Pyrophyte Acquisition Corp. II, covering the period from its inception on May 1, 2025, through June 30, 2025. Therefore, there are no prior period financial results to compare against. The filing reflects the company's pre-IPO financial state, characterized by minimal assets (primarily deferred offering costs) and a net loss of $102,000, primarily due to general and administrative expenses. Key financial events, such as the IPO and subsequent capital raises, occurred after the reporting period and will be reflected in future filings.

Key Financial Figures

• $0.0001 — nsisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemab
• $11.50 — ordinary share at an exercise price of $11.50 per share PAII WS New York Stock Exchan

Filing Documents

• ea0254776-10q_pyrophyte2.htm (10-Q) — 322KB
• ea025477601ex31-1_pyrophyte2.htm (EX-31.1) — 10KB
• ea025477601ex31-2_pyrophyte2.htm (EX-31.2) — 10KB
• ea025477601ex32-1_pyrophyte2.htm (EX-32.1) — 4KB
• ea025477601ex32-2_pyrophyte2.htm (EX-32.2) — 4KB
• 0001213900-25-083487.txt ( ) — 2598KB
• paii-20250630.xsd (EX-101.SCH) — 29KB
• paii-20250630_cal.xml (EX-101.CAL) — 10KB
• paii-20250630_def.xml (EX-101.DEF) — 139KB
• paii-20250630_lab.xml (EX-101.LAB) — 188KB
• paii-20250630_pre.xml (EX-101.PRE) — 177KB
• ea0254776-10q_pyrophyte2_htm.xml (XML) — 215KB

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 20 Item 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 24 Item 4.

CONTROLS AND PROCEDURES

CONTROLS AND PROCEDURES 24

- OTHER INFORMATION

PART II - OTHER INFORMATION Item 1.

LEGAL PROCEEDINGS

LEGAL PROCEEDINGS 25 Item 1A.

RISK FACTORS

RISK FACTORS 25 Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 25 Item 3. DEFAULTS UPON SENIOR SECURITIES 25 Item 4. MINE SAFETY DISCLOSURES 25 Item 5. OTHER INFORMATION 25 Item 6. EXHIBITS 26

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements PYROPHYTE ACQUISITION CORP. II UNAUDITED CONDENSED BALANCE SHEET June 30, 2025 ASSETS Deferred offering costs $ 217,104 Total assets $ 217,104 LIABILITIES AND SHAREHOLDERS' DEFICIT Current liabilities: Accounts payable $ 19,120 Accrued expenses 199,984 Promissory note – related party 75,000 Total current liabilities 294,104 Commitments and Contingencies (Note 5) Shareholders' Deficit Preference shares, $ 0.0001 par value; 1,000,000 shares authorized; none issued and outstanding - Class A ordinary shares, $ 0.0001 par value; 200,000,000 shares authorized; none issued and outstanding - Class B ordinary shares, $ 0.0001 par value; 20,000,000 shares authorized; 7,255,952 shares issued and outstanding (1) 726 Additional paid-in capital 24,274 Accumulated deficit ( 102,000 ) Total shareholders' deficit ( 77,000 ) Total Liabilities and Shareholders' Deficit $ 217,104 (1) This number includes an aggregate of up to 946,428 Class B shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On July 24, 2025, the underwriters partially exercised their over-allotment option and forfeited their right to purchase the remaining 83,850 units under the over-allotment option. As a result, the Sponsor forfeited 30,231 Class B Ordinary shares. (see Note 4). The accompanying notes are an integral part of these unaudited condensed financial statements. 1 PYROPHYTE ACQUISITION CORP. II UNAUDITED CONDENSED STATEMENT OF OPERATIONS For the period from May 1, 2025 (inception) through June 30, 2025 For the period from May 1, 2025 (inception) through June 30, 2025 General and administrative expenses $ 102,000 Net loss ( 102,000 ) Weighted average of Class B ordinary shares outstanding, basic and diluted (1) 6,309,524 Basic and diluted net loss per share, Class B ordinary shares subject to possible redemption $ ( 0.02 ) (1) This number excludes an aggregate of u

View Full Filing

View this 10-Q filing on SEC EDGAR